Memorial Sloan Kettering Cancer Center: Leukemia, Biphenotypic, Acute trials
The registry lists 10 Leukemia, Biphenotypic, Acute studies with Memorial Sloan Kettering Cancer Center as lead sponsor. 1 are open to participants now and 1 have results posted.
Phase 1 6Phase 2 3Phase 3 2No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of Revumenib and Mezigdomide in People With LeukemiaRecruitingNCT07356154Phase 1/2
- Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other DiseaseCompletedNCT00423514Phase 1/2Results posted
- Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With RadiotherapyCompletedNCT00606216
- Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute LeukemiaCompletedNCT00462787Phase 1
- Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced CancerCompletedNCT00045006Phase 1
- Pyroxamide in Treating Patients With Advanced CancerCompletedNCT00042900Phase 1
- Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic CancerCompletedNCT00014469Phase 2
- Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer TreatmentCompletedNCT00008359Phase 3
- Arsenic Trioxide in Treating Patients With Advanced Hematologic CancerCompletedNCT00003395Phase 1
- Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second RemissionCompletedNCT00002534Phase 3